Long-term effectiveness of surgical removal of Essure® implants: A retrospective cohort study

被引：1

作者：

Insubri, Sebastien ^{[2
]}

Bernard, Laure ^{[2
]}

Rubod, Chrystele ^{[1
,2
]}

Cosson, Michel ^{[1
,2
]}

Lallemant, Marine ^{[1
]}

Giraudet, Geraldine ^{[3
]}

机构：

[1] CHU Lille, Gynaecol Surg Dept, F-59000 Lille, France

[2] Univ Lille, F-59000 Lille, France

[3] Private Hosp Bois, F-59000 Lille, France

来源：

EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY | 2024年 / 303卷

关键词：

Adverse effects; Cornuectomy; Essure; Hysterectomy removal; FOLLOW-UP; PATIENT SATISFACTION; CASE SERIES; STERILIZATION; DEVICE; SYMPTOMS;

D O I：

10.1016/j.ejogrb.2024.10.047

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

Study objective: To assess symptom resolution and patient satisfaction following surgical explantation of Essure implants in the short and long term. Design: Retrospective monocentric cohort study (Lille Regional University Hospital, France). Setting: Essure is an implantable medical device for definitive sterilisation. Available from 2002, the Essure device has no longer been marketed since 2017. Following numerous reported side effects, the number of requests to withdraw Essure has steadily increased in recent years. Patients: All women who underwent Essure removal between December 2016 and January 2020 to assess the benefits of surgery on these symptoms and patient satisfaction at 6 weeks and 6 months after the procedure. Interventions: Removal of Essure implant with 4 types of surgery. Measurements: The benefits of the surgery were assessed using data from the postoperative consultation 6 to 8 weeks after surgery and then from a telephone call 6 months after surgery. Main results: 86 patients were explanted during the study period. Surgery proved beneficial, with a complete reduction in symptoms at 6 months in 74 % of these patients. Many symptoms were relieved by surgery, with complete resolution of symptoms in 62 % of cases for muscle pain, in 69 % of cases for asthenia, in 82 % of cases for abdominal pain and 100 % of cases for menorrhagia. Patient satisfaction was high, with 97.3 % of patients willing to repeat the procedure and 95.95 % recommending it to a friend. Conclusion: Removal of Essure implants in symptomatic patients appears to reduce all symptoms and improve quality of life in short and long term. Nevertheless, there are many symptoms associated with the insertion of Essure implants, and although surgery appears beneficial with good patient compliance, some adverse effects persist. It is therefore important to carry out a pre-operative etiological assessment and provide information on the risk of surgical failure.

引用

页码：212 / 217

页数：6

共 16 条

[1] Analysis of Adverse Events With Essure Hysteroscopic Sterilization Reported to the Manufacturer and User Facility Device Experience Database [J].

Al-Safi, Zain A. ;

Shavell, Valerie I. ;

Hobson, Deslyn T. G. ;

Berman, Jay M. ;

Diamond, Michael P. .

JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY, 2013, 20 (06) :825-829

[2]

Bahk Chi Y, 2015, Pharmaceut Med, V29, P331

[3] Essure Surgical Removal and Subsequent Symptom Resolution: Case Series and Follow-Up Survey [J].

Brito, Luiz Gustavo O. ;

Cohen, Sarah L. ;

Goggins, Emily R. ;

Wang, Karen C. ;

Einarsson, Jon I. .

JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY, 2015, 22 (05) :910-913

[4]

Cassidy BJ, 2019, Complete Essure Removal by Hysterectomy and Bilateral Salpingectomy for Treatment of Device-Associated Symptoms: A Case Series and Follow-up Survey, V2

[5] Essure Removal for the Treatment of Device-Attributed Symptoms: An Expanded Case Series and Follow-up Survey [J].